🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Allergen immunotherapy (AIT): Interesting bibliometric analysis: 2002-2021: pubmed.ncbi.nlm.nih.gov/36617823/

für meine Patientinnen und Patienten: bitte Termin vormerken ! DigiPat '23: TYP-2-Entzündungen, Asthma, Allergie auf Zahnmaterialien, Pollenallergie, Allergien auf Tierhaare, Anaphylaxie mein-allergie-portal.com/images/digipat…

Live from Dresden: AG Allergologie (DG HNO-KHC): meeting friends and top-experts in Rhinology

Watch this message from Oliver Pfaar - EAACI Congress Ambassador. Join us in Hamburg for the #EAACICongress2023 , an event that will offer the latest scientific breakthroughs, networking opportunities and countless possibilities to transform healthcare. ➡️ow.ly/jRvN50MZ2xg

Important reading: published today: AIT 111 years (part-2): also free access to all articles via Pubmed. dustri.com/nc/de/deutschs…

TV-Bericht über CRSwNP und Biologika: Nicht nur für Patienten interessant (sondern auch für Eintracht-Fans😀): youtube.com/watch?v=gQUhVW…

STERN Ärzteliste „Allergien“ 2023 stern.de/siegel/aerzte/…

jetzt online: "Therapie der chronischen Rhinosinusitis mit Polyposis nasi (CRScNP) mit monoklonalen Antikörpern (Biologika)" >> S2k-LL nach AWMF-Regelwerk samt Dokumentationsbogen und Evidenztabellen link.springer.com/content/pdf/10…

published (27 Mar 2023) & open access from our group: "Adherence and persistence in allergen immunotherapy (APAIT): a reporting checklist for retrospective studies" onlinelibrary.wiley.com/doi/abs/10.111…

für Patient*innen mit einer schweren Form der chronischen Nasennebenhöhlenentzündung mit Polypen (#CRSwNP): nehmen Sie gerne gleich mit uns Kontakt auf: Tel.: 06421 58 66933 EMail: [email protected] Wir freuen uns auf Ihre Kontaktaufnahme👍! Prof.Pfaar & Team

Open Access: Adherence and persistence in allergen immunotherapy (APAIT): a reporting checklist for retrospective studies. First and corresponding author: Oliver Pfaar Read the article here: doi.org/10.1111/all.15… The understanding of adherence or persistence to allergen

Just published from our group: read/enjoy/share. Thank you, Oliver "Improvement of daily allergy control by sublingual immunotherapy: A MASK-air® study" (via #pubmedontap) ncbi.nlm.nih.gov/pubmed/37070243

Berlin, 24.Mai :  16. Runder Tisch Allergologie  Wichtige berufspolitische Akzente mit gesundheitspolitischen Sprecher*innen des Deutschen Bundestages, GKV-Spitzenverbänden und Industrie: klarer Auftrag: PRO Allergologie und AIT !!!

On my way to Hamburg, Germany: Annual EAACI congress 2023: excited to meet so many colleagues and friends again. 4 days long !!! Find me in the programme: great to have you in the rooms or remote. Oliver

EAACI congress 2023 …so great to meet both KOLs and friends again!

Very recently published in WAO from our US- and EU-expert network: Comparison of allergen immunotherapy practice patterns in inhalant allergies in the US and Europe: Similarities and differences 2023: Unmet needs of AIT! Read/Enjoy/Share. Thanks, Oliver pubmed.ncbi.nlm.nih.gov/37251813/

For experts and stakeholders in AIT-research: EAACI Task-Force Position Paper on 'Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma' Read/Enjoy/Share. Best, Oliver pubmed.ncbi.nlm.nih.gov/37449468/

no longer on X (former Twitter). Reach me though: linkedin.com/in/oliver-prof… or EMail: [email protected]